As of 2025-12-27, the Relative Valuation of Britannia Life Sciences Inc (BLAB.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.09 CAD, the upside of Britannia Life Sciences Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-12-19 | -6.82 |
| 2025-12-18 | -7.22 |
| 2025-12-17 | -6.82 |
| 2025-12-16 | -6.82 |
| 2025-12-15 | -7.22 |
| 2025-12-10 | -7.22 |
| 2025-12-09 | -6.42 |
| 2025-12-04 | -7.22 |
| 2025-12-03 | -6.82 |
| 2025-12-02 | -6.82 |
| 2025-12-01 | -7.22 |
| 2025-11-28 | -7.22 |
| 2025-11-27 | -7.22 |
| 2025-11-26 | -7.22 |
| 2025-11-24 | -7.22 |
| 2025-11-21 | -7.22 |
| 2025-11-20 | -7.22 |
| 2025-11-17 | -7.62 |
| 2025-11-14 | -8.02 |
| 2025-11-13 | -7.62 |
| 2025-11-12 | -7.62 |
| 2025-11-10 | -8.02 |
| 2025-11-07 | -8.02 |
| 2025-11-06 | -8.02 |
| 2025-11-04 | -8.42 |
| 2025-11-03 | -8.42 |
| 2025-10-31 | -8.83 |
| 2025-10-28 | -7.62 |
| 2025-10-27 | -7.62 |
| 2025-10-23 | -7.62 |
| 2025-10-22 | -7.62 |
| 2025-10-21 | -7.62 |
| 2025-10-20 | -7.62 |
| 2025-10-17 | -7.62 |
| 2025-10-15 | -8.02 |
| 2025-10-14 | -8.02 |
| 2025-10-10 | -8.42 |
| 2025-10-09 | -8.02 |
| 2025-10-08 | -7.62 |
| 2025-10-07 | -7.62 |
| 2025-10-06 | -11.23 |
| 2025-10-03 | -7.62 |
| 2025-10-02 | -6.82 |
| 2025-09-29 | -6.82 |
| 2025-09-26 | -7.62 |
| 2025-09-25 | -7.62 |